MARCKS Inhibition Alters Bovine Neutrophil Responses to Salmonella Typhimurium

Haleigh E Conley1,2, Chalise F Brown1, Trina L Westerman3

  • 1Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.

Biomedicines
|February 24, 2024
PubMed

Insights

Inhibiting Myristoylated alanine-rich C-kinase substrate (MARCKS) in neutrophils altered responses to Salmonella Typhimurium. MARCKS inhibition reduced adhesion and chemotaxis but enhanced phagocytosis and respiratory burst.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Neutrophils are key innate immune cells crucial for combating bacterial infections.
  • Certain pathogens, like Salmonella, exploit neutrophil inflammation for colonization and pathogenesis.
  • Neutrophils' role in Salmonella infection makes them a potential target for host-directed therapies.

Purpose of the Study:

  • To investigate the role of Myristoylated alanine-rich C-kinase substrate (MARCKS) in bovine neutrophil responses to Salmonella Typhimurium (STm).
  • To determine if inhibiting MARCKS affects neutrophil functions during STm infection.

Main Methods:

  • Utilized a specific MARCKS inhibitor peptide.
  • Ex vivo analysis of bovine neutrophils exposed to STm.
  • Assessed neutrophil adhesion, chemotaxis, phagocytosis, and respiratory burst.

Main Results:

  • MARCKS inhibition significantly attenuated STm-induced neutrophil adhesion and chemotaxis.
  • Conversely, MARCKS inhibition enhanced neutrophil phagocytosis of STm.
  • MARCKS inhibition also boosted the respiratory burst activity of neutrophils against STm.

Conclusions:

  • This study is the first to describe the role of MARCKS protein in neutrophil antibacterial responses.
  • MARCKS is a critical regulator of neutrophil effector functions against Salmonella Typhimurium.
  • Targeting MARCKS may offer a novel host-directed therapeutic strategy against Salmonella infections.